Amylyx to pull failed ALS drug from market, cut 70% of staff fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.
ALS Drug Will Be Pulled From US Market After Study Showed Patients Didn t Benefit usnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from usnews.com Daily Mail and Mail on Sunday newspapers.
Relyvrio's withdrawal leaves just three ALS medicines available to U.S. patients, only one of which has been shown to extend survival by several months.
ALS Drug Will Be Pulled From US Market After Study Showed Patients Didn t Benefit – 710am KURV kurv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kurv.com Daily Mail and Mail on Sunday newspapers.
(Reuters) -Amylyx Pharmaceuticals will withdraw its amyotrophic lateral sclerosis (ALS) drug - its only product in the market - from the U.S. and Canada .